These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32604308)

  • 41. Purpura Fulminans in Toxic Epidermal Necrolysis: Case Report and Review.
    Jones E; Stair-Buchmann M; Kotliar S; Haith L
    J Burn Care Res; 2015; 36(6):e274-82. PubMed ID: 25412057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toxic epidermal necrolysis. A case report.
    Villalta P; Velez I; Mejia L; Ospina AM
    J Clin Pediatr Dent; 2010; 35(2):197-8. PubMed ID: 21417124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progressive bronchial obstruction associated with toxic epidermal necrolysis.
    Minamihaba O; Nakamura H; Sata M; Inage M; Shirakabe M; Tanida H; Osada Y; Kondo S; Tomoike H
    Respirology; 1999 Mar; 4(1):93-5. PubMed ID: 10339737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Possible involvement of gelatinase A (MMP2) and gelatinase B (MMP9) in toxic epidermal necrolysis or Stevens-Johnson syndrome.
    Gaultier F; Ejeil AL; Igondjo-Tchen S; Dohan D; Dridi SM; Maman L; Wierzba CB; Stania D; Pellat B; Lafont A; Godeau G; Gogly B
    Arch Dermatol Res; 2004 Oct; 296(5):220-5. PubMed ID: 15449075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toxic epidermal necrolysis: a paradigm of critical illness.
    Estrella-Alonso A; Aramburu JA; González-Ruiz MY; Cachafeiro L; Sánchez MS; Lorente JA
    Rev Bras Ter Intensiva; 2017; 29(4):499-508. PubMed ID: 29340540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study.
    Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK
    BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stevens-Johnson syndrome in childhood.
    Blanco N; Gutiérrez B; Valls I; Puertas D; Martín C; Rivera M; Hernández Á; Torrelo A
    Arch Soc Esp Oftalmol; 2017 May; 92(5):241-244. PubMed ID: 27899204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toxic epidermal necrolysis probably due to cosmetic cream: a case report.
    Kokcam I
    Acta Dermatovenerol Alp Pannonica Adriat; 2009 Mar; 18(1):39-42. PubMed ID: 19350188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Lip synechiae after erythema multiforme].
    Brajon D; Bursztejn AC; Goffinet L; Schmutz JL; Barbaud A
    Ann Dermatol Venereol; 2013 Apr; 140(4):291-5. PubMed ID: 23567232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toxic epidermal necrolysis complicated by delayed mucosal healing and haemorrhagic mucositis.
    Dawe S; Bentley R; Creamer D
    Clin Exp Dermatol; 2003 Jul; 28(4):454-5. PubMed ID: 12823319
    [No Abstract]   [Full Text] [Related]  

  • 53. Severe Physical Complications among Survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Olteanu C; Shear NH; Chew HF; Hashimoto R; Alhusayen R; Whyte-Croasdaile S; Finkelstein Y; Burnett M; Ziv M; Sade S; Jeschke MG; Dodiuk-Gad RP
    Drug Saf; 2018 Mar; 41(3):277-284. PubMed ID: 29052094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toxic epidermal necrolysis with extensive mucosal erosions of the gastrointestinal and respiratory tracts.
    Roupe G; Ahlmén M; Fagerberg B; Suurküla M
    Int Arch Allergy Appl Immunol; 1986; 80(2):145-51. PubMed ID: 3710608
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Case report: psychosis with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    de Rego JA; Goldstein DM
    Hillside J Clin Psychiatry; 1985; 7(2):141-8. PubMed ID: 4077031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients.
    Revuz J; Penso D; Roujeau JC; Guillaume JC; Payne CR; Wechsler J; Touraine R
    Arch Dermatol; 1987 Sep; 123(9):1160-5. PubMed ID: 3632000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stevens-Johnson syndrome induced by sorafenib for metastatic renal cell carcinoma.
    Ikeda M; Fujita T; Amoh Y; Mii S; Matsumoto K; Iwamura M
    Urol Int; 2013; 91(4):482-3. PubMed ID: 23969404
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme.
    Roujeau JC
    J Dermatol; 1997 Nov; 24(11):726-9. PubMed ID: 9433029
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fever in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Pediatric Cases: Laboratory Work-up and Antibiotic Therapy.
    Paulmann M; Mockenhaupt M
    Pediatr Infect Dis J; 2017 May; 36(5):513-515. PubMed ID: 28403057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Toxic epidermal necrolysis and development of liver abscesses].
    Domínguez-Borgúa A; González I; Morales L; Martínez-Carrillo FM; Palacios P
    Gac Med Mex; 2015; 151(4):512-8. PubMed ID: 26290028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.